Note: Ingredients listed on restricted chemical lists
EC/CAS
204-650-8/123-77-3
Name of the chemical
Diazene-1,2-dicarboxamide [C,C`-azodi(formamide), ADCA]
Concentration
<=100%
General Information
Version
6.8
Revision date
2024-07-02
Product name
Azodicarboxamide for synthesis
CAS No.
123-77-3
1.2.1 Relevant identified uses
Chemical for synthesis
Emergency telephone
800-424-9300, +1-703- 527-3887
Icons in SDS
Company Information
company name
Sigma-Aldrich Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H228, H334, H402
Hazard statements
Code
Statements
H228
Flammable solid
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture
Signal word
Danger
Hazard statements
H228 Flammable solid. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H402 Harmful to aquatic life.
Precautionary statements
P210 Keep away from heat/ sparks/ open flames/ hot surfaces. No smoking. P240 Ground/bond container and receiving equipment. P241 Use explosion-proof electrical/ ventilating/ lighting/ equipment. P261 Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P273 Avoid release to the environment. P280 Wear protective gloves/ eye protection/ face protection. P285 In case of inadequate ventilation wear respiratory protection. P304 + P341 IF INHALED: If breathing is difficult, remove person to fresh air and keep comfortable for breathing. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor. P370 + P378 In case of fire: Use dry sand, dry chemical or alcohol-resistant foam to extinguish. P501 Dispose of contents/ container to an approved waste disposal plant.
2.3 Other hazards
Risk of explosion if heated under confinement.
2.1 Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) Flammable solids (Category 1), H228 Respiratory sensitization (Category 1), H334 Short-term (acute) aquatic hazard (Category 3), H402 For the full text of the H-Statements mentioned in this Section, see Section 16.